BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 3338977)

  • 1. Patterns of plasma imipramine-desipramine concentrations in patients receiving concomitant fluphenazine decanoate.
    Siris SG; Adan F; Lee A; Cooper TB; Mandeli J; Casey E
    J Clin Psychiatry; 1988 Feb; 49(2):64-5. PubMed ID: 3338977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluvoxamine-induced alterations in plasma concentrations of imipramine and desipramine in depressed patients.
    Spina E; Pollicino AM; Avenoso A; Campo GM; Caputi AP
    Int J Clin Pharmacol Res; 1993; 13(3):167-71. PubMed ID: 8225700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuation and maintenance treatment trials of adjunctive imipramine therapy in patients with postpsychotic depression.
    Siris SG; Strahan A
    J Clin Psychiatry; 1988 Nov; 49(11):439-40. PubMed ID: 3182733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Excessive plasma concentration of tricyclic antidepressants resulting from usual doses: a report of six cases.
    Devane CL; Wolin RE; Rovere RA; Panahon NC; Sutfin TA; Jusko WJ
    J Clin Psychiatry; 1981 Apr; 42(4):143-7. PubMed ID: 7204359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Depression in children: relationship between plasma imipramine levels and response.
    Preskorn SH; Weller EB; Weller RA
    J Clin Psychiatry; 1982 Nov; 43(11):450-3. PubMed ID: 7174621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma concentrations of tricyclic antidepressants in clinical practice.
    Hollister LE
    J Clin Psychiatry; 1982 Feb; 43(2):66-9. PubMed ID: 7056706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response of postpsychotic depression to adjunctive imipramine or amitriptyline.
    Siris SG; Rifkin AE; Reardon GT
    J Clin Psychiatry; 1982 Dec; 43(12):485-6. PubMed ID: 6131064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjunctive imipramine maintenance treatment in schizophrenic patients with remitted postpsychotic depression.
    Siris SG; Cutler J; Owen K; Mason S; Gingerich S; Lang MP
    Am J Psychiatry; 1989 Nov; 146(11):1495-7. PubMed ID: 2817126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma imipramine concentrations in patients receiving concomitant fluphenazine decanoate.
    Siris SG; Cooper TB; Rifkin AE; Brenner R; Lieberman JA
    Am J Psychiatry; 1982 Jan; 139(1):104-6. PubMed ID: 7055248
    [No Abstract]   [Full Text] [Related]  

  • 10. Adjunctive imipramine in the treatment of postpsychotic depression. A controlled trial.
    Siris SG; Morgan V; Fagerstrom R; Rifkin A; Cooper TB
    Arch Gen Psychiatry; 1987 Jun; 44(6):533-9. PubMed ID: 3555386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical usefulness of monitoring serum levels of imipramine and desipramine in patients treated for endogenous depression].
    Szymura-Oleksiak J; Wasieczko A
    Psychiatr Pol; 1991; 25(1):54-60. PubMed ID: 1780375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuation treatment with adjunctive imipramine in schizophrenia.
    Siris SG; Bermanzohn PC; Mason SE; Shuwall MA; Aseniero MA
    Psychopharmacol Bull; 1992; 28(3):303-7. PubMed ID: 1480734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated plasma tricyclic levels with therapeutic doses of imipramine.
    Garvey MJ; Tuason VB; Johnson RA; Valentine RH; Cooper TB
    Am J Psychiatry; 1984 Jul; 141(7):853-6. PubMed ID: 6731633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imipramine and desipramine plasma levels: relationship to dosage schedule and sampling time.
    Ziegler VE; Biggs JT; Rosen SH; Meyer DA; Preskorn SH
    J Clin Psychiatry; 1978 Aug; 39(8):660-3. PubMed ID: 681303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum neuroleptic levels during reduced dose fluphenazine decanoate maintenance therapy.
    Heresco-Levy U; Greenberg D; Lerer B; Javitt DC; Brown WA
    Isr J Psychiatry Relat Sci; 1997; 34(4):281-9. PubMed ID: 9409085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum neuroleptic levels and clinical outcome in schizophrenic patients treated with fluphenazine decanoate.
    Brown WA; Silver MA
    J Clin Psychopharmacol; 1985 Jun; 5(3):143-7. PubMed ID: 3998204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imipramine and tinnitus.
    Tandon R; Grunhaus L; Greden JF
    J Clin Psychiatry; 1987 Mar; 48(3):109-11. PubMed ID: 3818550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antidepressants in the treatment of post-psychotic depression in schizophrenia: drug interactions and other considerations.
    Siris SG; Sellew AP; Frechen K; Cooper TB; Mandell J; Casey E
    Clin Chem; 1988 May; 34(5):837-40. PubMed ID: 3286051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum imipramine concentrations lower than plasma values.
    Hullett FJ; Levy AB; Tachiki KH
    J Clin Psychiatry; 1984 Dec; 45(12):516-8. PubMed ID: 6501238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tricyclic-resistant depression: treatment resistance or inadequate treatment?
    Lydiard RB
    J Clin Psychiatry; 1985 Oct; 46(10):412-7. PubMed ID: 3900051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.